本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Biohaven Pharmaceutical Holding Co Ltd.

14.46
+0.07000.49%
盤後14.460.00000.00%19:08 EDT
成交量:278.87萬
成交額:4,010.20萬
市值:14.77億
市盈率:-1.57
高:14.63
開:14.48
低:13.87
收:14.39
資料載入中...
2023/05/31

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/12

重要事件披露

Form 8-K - Current report
2022/10/04

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/03

重要事件披露

8-K - Current report
2022/09/29

重要事件披露

8-K - Current report
2022/09/27

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/05

重要事件披露

8-K - Current report
2022/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/28

重要事件披露

8-K - Current report
2022/06/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals